UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 196

Sortiert nach

Adjuvante Therapie des Endometriumkarzinoms

Die Gynäkologie, 2022-07, Vol.55 (7), p.501-508

2022

Volltextzugriff (PDF)

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

Annals of oncology, 2012-07, Vol.23 (7), p.1795-1802

2012

Volltextzugriff (PDF)

Adjuvante Therapie des Endometriumkarzinoms

Gynäkologe (Berlin), 2018-12, Vol.51 (12), p.1032-1036

2018

Volltextzugriff (PDF)

Front-line therapy of advanced epithelial ovarian cancer: standard treatment

Annals of oncology, 2017-11, Vol.28 (suppl_8), p.viii36-viii39

2017

Volltextzugriff (PDF)

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer

Oncogene, 2011-09, Vol.30 (38), p.4038-4049

2011

Volltextzugriff (PDF)

An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature

Gynecologic oncology reports, 2024-08, Vol.54, p.101442, Article 101442

2024

Volltextzugriff (PDF)

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Gynecologic oncology, 2013-10, Vol.131 (1), p.15-20

2013

Volltextzugriff (PDF)

Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries

Annals of oncology, 2018-04, Vol.29 (4), p.910-916

2018

Volltextzugriff (PDF)

713 Palbociclib and metformin show anticancer efficacy in high grade serous ovarian cancer

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A263-A264

2021

Volltextzugriff (PDF)

P132 Significance of locus-specific TP53 mutations in ovarian cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A139-A139

2019

Volltextzugriff (PDF)

Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)

International journal of gynecological cancer, 2023-02, Vol.33 (2), p.223-230

2023

Volltextzugriff (PDF)

Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)

Annals of oncology, 2016-09, Vol.27 (9), p.1740-1746

2016

Volltextzugriff (PDF)

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

Gene therapy, 2002-08, Vol.9 (16), p.1093-1100

2002

Volltextzugriff (PDF)

EP891 Receptor activator of nuclear factor kappa-B ligand expression predicts ovarian cancer outcome

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A482-A483

2019

Volltextzugriff (PDF)

Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer

Cancer research (Chicago, Ill.), 1997-10, Vol.57 (19), p.4158-4161

1997

Volltextzugriff (PDF)

DNA hypomethylation and ovarian cancer biology

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4472-4480

2004

Volltextzugriff (PDF)

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

Oncogene, 2010-04, Vol.29 (13), p.1997-2004

2010

Volltextzugriff (PDF)

P139 The role of transcriptomic SMARCA4 expression in ovarian cancer biology

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A142-A142

2019

Volltextzugriff (PDF)

EP1004 Prognostic impact of BRCA2 mRNA expression in ovarian cancer: validation using the TCGA cohort

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A530-A530

2019

Volltextzugriff (PDF)

P155 The microRNA 34 family and its clinical significance in ovarian cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A153-A153

2019

Volltextzugriff (PDF)

382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative

International journal of gynecological cancer, 2021-10, Vol.31 (Suppl 3), p.A87-A88

2021

Volltextzugriff (PDF)

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

British journal of cancer, 2011-11, Vol.105 (10), p.1593-1599

2011

Volltextzugriff (PDF)

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1861-1868

1998

Volltextzugriff (PDF)

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Annals of oncology, 2019-05, Vol.30 (5), p.672-705

2019

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Adjuvante Therapie des Endometriumkarzinoms

Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation

Adjuvante Therapie des Endometriumkarzinoms

Front-line therapy of advanced epithelial ovarian cancer: standard treatment

Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer

An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries

713 Palbociclib and metformin show anticancer efficacy in high grade serous ovarian cancer

P132 Significance of locus-specific TP53 mutations in ovarian cancer

Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)

Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

EP891 Receptor activator of nuclear factor kappa-B ligand expression predicts ovarian cancer outcome

Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer

DNA hypomethylation and ovarian cancer biology

Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer

P139 The role of transcriptomic SMARCA4 expression in ovarian cancer biology

EP1004 Prognostic impact of BRCA2 mRNA expression in ovarian cancer: validation using the TCGA cohort

P155 The microRNA 34 family and its clinical significance in ovarian cancer

382 Molecular classification of endometrial carcinoma substantially changing risk-assessment: Results from a european multicentre initiative

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer

Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Suchergebnisse filtern